Abdul Ashish
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
-
- Intensive Care Unit Cognitive Disorders
Papers in
-
- Cystic Fibrosis Research Advances 6
- Respiratory Support and Mechanisms 2
- Inhalation and Respiratory Drug Delivery 2
-
- Long-Term Effects of COVID-19 3
- Co-authors
- Martin Walshaw (6 shared papers)Craig Winstanley (4 shared papers)Tarek Gaber (1 shared paper)Matthew Shaw (4 shared papers)M.J. Ledson (4 shared papers)Joanne L. Fothergill (2 shared papers)Steve Paterson (1 shared paper)Eilidh Mowat (2 shared papers)
- Journals
- Journal of Cystic Fibrosis (4 papers)Thorax (2 papers)European Respiratory Journal (2 papers)Journal of Primary Care & Community Health (1 paper)BMJ Open Respiratory Research (1 paper)
- Partner nations
- United KingdomIndiaDenmark
In The Last Decade
Abdul Ashish
16 papers receiving 250 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 65
- Critical Care and Intensive Care Medicine 34
- Neurology 70
- Pulmonary and Respiratory Medicine 116
- Endocrinology 16
Countries citing papers authored by Abdul Ashish
This map shows the geographic impact of Abdul Ashish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Ashish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Ashish more than expected).
Fields of papers citing papers by Abdul Ashish
This network shows the impact of papers produced by Abdul Ashish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Ashish. The network helps show where Abdul Ashish may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdul Ashish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 64 | |
| 2 | 2013 | 43 | |
| 3 | 2011 | 41 | |
| 4 | 2013 | 39 | |
| 5 | 2020 | 39 | |
| 6 | 2012 | 16 | |
| 7 | 2025 | 3 | |
| 8 | 2010 | 2 | |
| 9 | 2013 | 1 | |
| 10 | 2013 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2010 | 1 | |
| 14 | 2010 | 1 | |
| 15 | Vitamin D and COVID-19 Infection. | 2021 | 1 |
| 16 | 2013 | 1 | |
| 17 | 2022 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2021 | 0 |
About Abdul Ashish
Abdul Ashish is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Epidemiology, Molecular Medicine and Physiology, having authored 20 papers that have together received 255 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (6 papers), Long-Term Effects of COVID-19 (3 papers), Antibiotic Resistance in Bacteria (3 papers), Bacterial biofilms and quorum sensing (2 papers), Respiratory Support and Mechanisms (2 papers), COVID-19 Clinical Research Studies (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Clinical practice guidelines implementation (1 paper). The work is most often cited by research in Molecular Medicine (65 citations), Critical Care and Intensive Care Medicine (34 citations), Neurology (70 citations), Pulmonary and Respiratory Medicine (116 citations) and Endocrinology (16 citations). Abdul Ashish has collaborated with scholars based in United Kingdom, India and Denmark. Frequent co-authors include Martin Walshaw, Craig Winstanley, Tarek Gaber, Matthew Shaw, M.J. Ledson, Joanne L. Fothergill, Steve Paterson, Eilidh Mowat, Jane Martindale and Luigi Sedda. Their work appears in journals such as Journal of Cystic Fibrosis, Thorax, European Respiratory Journal, Journal of Primary Care & Community Health and BMJ Open Respiratory Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.